IPRATROPIUM BROMIDESALBUTAMOL CIPLA

Main information

  • Trade name:
  • IPRATROPIUM BROMIDESALBUTAMOL CIPLA Nebuliser solution 0,5MG/2,5ML+2,5MG/2,5ML
  • Dosage:
  • 0,5MG/2,5ML+2,5MG/2,5ML
  • Pharmaceutical form:
  • Nebuliser solution
  • Administration route:
  • Inhalation use
  • Units in package:
  • 80X2,5ML Ampoule
  • Prescription type:
  • on prescription
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • IPRATROPIUM BROMIDESALBUTAMOL CIPLA Nebuliser solution 0,5MG/2,5ML+2,5MG/2,5ML
    Czech Republic
  • Language:
  • English

Therapeutic information

  • Therapeutic area:
  • Salbutamol and ipratropium bromide
  • Product summary:
  • IPRATROPIUM BROMIDE/SALBUTAMOL CIPLA

Other information

Status

  • Source:
  • SUKL - Státní ústav pro kontrolu léčiv
  • Authorization status:
  • R - active MA/authorised medicinal product
  • Authorization number:
  • 14/ 138/15-C
  • Last update:
  • 28-02-2017